ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,297.10
-0.21%
US Tech 100
18,079.20
-0.20%
Dow Jones
39,869.38
-0.10%
Brent Oil
83.305
0.12%
Bitcoin
65,542.54
0.46%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Genuit Group Plc (GEN)

  7. Genuit Group Plc (GEN) News

GEN

Genuit (GEN)

Genuit Group Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:GEN
DateTimeSourceHeadlineSymbolCompany
05/14/20243:00AMPR Newswire (US)Deepfakes, AI-Manipulated Audio, and Hijacked Social Media Surge in 2024LSE:GENGenuit Group Plc
05/02/202411:57AMRNS Regulatory NewsGenuit Group PLC Block listing Interim ReviewLSE:GENGenuit Group Plc
04/24/20245:39AMRNS Regulatory NewsGenuit Group PLC Notice of AGMLSE:GENGenuit Group Plc
04/10/202411:24AMRNS Regulatory NewsGenuit Group PLC Director/PDMR ShareholdingLSE:GENGenuit Group Plc
04/10/202411:17AMRNS Regulatory NewsGenuit Group PLC Director/PDMR ShareholdingLSE:GENGenuit Group Plc
04/09/202411:28AMRNS Regulatory NewsGenuit Group PLC Director DeclarationLSE:GENGenuit Group Plc
04/02/202410:56AMRNS Regulatory NewsGenuit Group PLC Director/PDMR ShareholdingLSE:GENGenuit Group Plc
03/20/202411:27AMRNS Regulatory NewsGenuit Group PLC Director/PDMR ShareholdingLSE:GENGenuit Group Plc
03/12/20246:40AMAlliance NewsAlliance NewsGenuit revenue drops on lower divisional sales but profit surgesLSE:GENGenuit Group Plc
03/12/20243:09AMAlliance NewsAlliance News*Genuit says 2024 trading has started in line w/ expectations, despite market uncertaintyLSE:GENGenuit Group Plc
03/12/20243:09AMAlliance NewsAlliance News*Genuit declares total dividend per share of 12.4p vs 12.3p YoYLSE:GENGenuit Group Plc
03/12/20243:07AMAlliance NewsAlliance News*Genuit 2023 pretax profit GBP48.4m vs GBP45.4m YoYLSE:GENGenuit Group Plc
03/12/20243:00AMRNS Regulatory NewsGenuit Group PLC Final ResultsLSE:GENGenuit Group Plc
03/01/20243:30AMRNS Regulatory NewsGenuit Group PLC Director DeclarationLSE:GENGenuit Group Plc
02/19/20244:00AMRNS Regulatory NewsGenuit Group PLC Notice of Results and Investor PresentationLSE:GENGenuit Group Plc
01/23/202410:49AMUK RegulatoryGenuit Group PLC Holding(s) in CompanyLSE:GENGenuit Group Plc
01/23/20246:24AMUK RegulatoryGenmab A/S Genmab Announces Net Sales Of Darzalex(R) (daratumumab) For 2023LSE:GENGenuit Group Plc
01/22/20246:40PMUK RegulatoryGenmab A/S Genmab Announces Decision In Arbitration Appeal Under License Agreement With JanssenLSE:GENGenuit Group Plc
01/09/20246:45AMUK RegulatoryGenmab A/S Tivdak(R) (tisotumab vedotin-tftv) Supplemental Biologics License Application Accepted For Priority Review By U.S. Food And Drug Administration For Patients With Recurrent Or Metastatic Cervical CancerLSE:GENGenuit Group Plc
01/03/202412:55AMUK RegulatoryGenmab A/S Transactions With Shares And Linked Securities In Genmab A/S Made By Managerial Employees And Their Closely Associated PersonsLSE:GENGenuit Group Plc
01/02/20249:52AMUK RegulatoryGenmab A/S Genmab To Present At The 42nd Annual J.P. Morgan Healthcare ConferenceLSE:GENGenuit Group Plc
12/12/20237:00AMUK RegulatoryGenmab A/S Genmab To Hold 2023 R&D Update And Ash Data Review MeetingLSE:GENGenuit Group Plc
12/09/202312:00PMUK RegulatoryGenmab A/S New Pivotal Data For Bispecific Antibody Epcoritamab (DuoBody(R) Cd3xcd20) Demonstrates High Overall And Complete Responses In Patients With Hard-To-Treat Relapsed/Refractory Follicular Lymphoma (FL)LSE:GENGenuit Group Plc
12/05/20235:26PMUK RegulatoryGenmab A/S Capital Increase In Genmab As A Result Of Employee Warrant ExerciseLSE:GENGenuit Group Plc
11/27/20237:00AMUK RegulatoryGenmab A/S Genmab Announces Positive Regulatory Updates For Epcoritamab (EPKINLY(R)/Tepkinly(R)) For The Treatment Of Relapsed/Refractory Follicular LymphomaLSE:GENGenuit Group Plc
11/22/20232:00AMUK RegulatoryGenuit Group PLC Strategy Progress Update NotificationLSE:GENGenuit Group Plc
11/21/20234:45PMUK RegulatoryGenmab A/S Transactions With Shares And Linked Securities In Genmab A/S Made By Managerial Employees And Their Closely Associated PersonsLSE:GENGenuit Group Plc
11/21/20234:42PMUK RegulatoryGenmab A/S Grant Of Restricted Stock Units To Board Members And Employees And Grant Of Warrants To Employees In GenmabLSE:GENGenuit Group Plc
11/15/20234:03AMAlliance NewsAlliance NewsGenuit shares rise as annual profit predicted to exceed expectationsLSE:GENGenuit Group Plc
11/15/20232:00AMUK RegulatoryGenuit Group PLC Trading UpdateLSE:GENGenuit Group Plc
 Showing the most relevant articles for your search:LSE:GEN

Your Recent History

BIT
I06560
Banca Imi
BIT
S27207
Societe Generale Effekten
NYSE
GJR
Synthetic Fixed Income S...
BIT
UB5FXC
Unicredit Bank
AMEX
SGDJ
Sprott Junior Gold Miner...
BIT
IGV
I Grandi Viaggi
BIT
RCS
Rizzoli Corriere della S...
XE
SLSA
Solutiance
EU
2484T
2484T
BOV
RAILH230
RAILH230 Ex:22,91
NYSE
HYV
BIT
P13ZJ4
BNP Paribas Issuance
LSE
0OB3
Valneva
BIT
DLG
De Longhi
BIT
UB9LM0
Unicredit Bank
BIT
UB6DCH
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved